299 related articles for article (PubMed ID: 10586938)
1. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
[TBL] [Abstract][Full Text] [Related]
3. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
Maeda T; Maeda A; Maruyama I; Ogawa KI; Kuroki Y; Sahara H; Sato N; Ohguro H
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
[TBL] [Abstract][Full Text] [Related]
5. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
6. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
Maeda A; Ohguro H; Maeda T; Wada I; Sato N; Kuroki Y; Nakagawa T
Cancer Res; 2000 Apr; 60(7):1914-20. PubMed ID: 10766180
[TBL] [Abstract][Full Text] [Related]
8. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunologic aspects of cancer-associated retinopathy.
Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
Maeda A; Maeda T; Liang Y; Yenerel M; Saperstein DA
Mol Vis; 2006 Aug; 12():885-91. PubMed ID: 16917481
[TBL] [Abstract][Full Text] [Related]
11. Retinal uptake of intravitreally injected Hsc/Hsp70 and its effect on susceptibility to light damage.
Yu Q; Kent CR; Tytell M
Mol Vis; 2001 Mar; 7():48-56. PubMed ID: 11239246
[TBL] [Abstract][Full Text] [Related]
12. Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro.
Chen W; Elias RV; Cao W; Lerious V; McGinnis JF
J Neurosci Res; 1999 Sep; 57(5):706-18. PubMed ID: 10462694
[TBL] [Abstract][Full Text] [Related]
13. [Carcinoma-associated retinopathy].
Ohguro H; Maruyama I
Ryoikibetsu Shokogun Shirizu; 2000; (31):73-6. PubMed ID: 11269192
[No Abstract] [Full Text] [Related]
14. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats.
Adamus G; Ortega H; Witkowska D; Polans A
Exp Eye Res; 1994 Oct; 59(4):447-55. PubMed ID: 7859820
[TBL] [Abstract][Full Text] [Related]
15. Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy.
Polans AS; Burton MD; Haley TL; Crabb JW; Palczewski K
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):81-90. PubMed ID: 8425844
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic retinopathy and anti-recoverin antibodies].
Bataller L; Graus F; Dalmau J
Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
[No Abstract] [Full Text] [Related]
17. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
18. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy.
Potter MJ; Thirkill CE; Dam OM; Lee AS; Milam AH
Ophthalmology; 1999 Nov; 106(11):2121-5. PubMed ID: 10571347
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice.
Maeda A; Maeda T; Ohguro H; Palczewski K; Sato N
Eur J Immunol; 2002 Aug; 32(8):2300-7. PubMed ID: 12209643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]